For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Kodiak Sciences Inc.

USPTO Granted Patents = 14

% Expired Patents = 7.1

EPO Patents = 9

Forward Citations = 65

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Daniel Victor Perlroth (10 out of 10 patents)

Wayne To (8 out of 18 patents)

Stephen A Charles (8 out of 22 patents)

4. Didier G Benoit (7 out of 16 patents)

5. Hong Liang (6 out of 11 patents)

6. James Bradley Aggen (5 out of 51 patents)

7. Martin Sheringham Linsell (5 out of 82 patents)

8. D Victor Perlroth (4 out of 7 patents)

9. Wah Yuen To (3 out of 3 patents)

10. Li Song (3 out of 6 patents)

11. Fernando Corrêa (3 out of 3 patents)

12. Lidia Mosyak (2 out of 16 patents)

13. Laura Lin (2 out of 11 patents)

14. Justin Cohen (2 out of 3 patents)

15. Tetsuya Ishino (2 out of 7 patents)

14 patents: Sort by Forward Citations

1. 12643958 - METHODS OF TREATING AN EYE DISORDER (2026-06-02),

2. 12466879 - COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF (2025-11-11),

3. 12214044 - Factor VIII zwitterionic polymer conjugates (2025-02-04),

4. 12071476 - IL-6 antibodies and fusion constructs and conjugates thereof (2024-08-27),

5. 11912784 - Methods of treating an eye disorder (2024-02-27),

6. 11819531 - Multifunctional zwitterionic polymer conjugates (2023-11-21),

7. 11590235 - Factor VIII zwitterionic polymer conjugates (2023-02-28),

8. 11584790 - Complement factor D antagonist antibodies and conjugates thereof (2023-02-21),

9. 11155610 - Dual PDGF/VEGF antagonists (2021-10-26),

10. 11071771 - Butyrylcholinesterase zwitterionic polymer conjugates (2021-07-27),

11. 11066465 - Antibodies and conjugates thereof (2021-07-20),

12. 10702608 - Factor VIII zwitterionic polymer conjugates (2020-07-07),

13. 10363290 - Butyrylcholinesterase zwitterionic polymer conjugates (2019-07-30),

14. 9840553 - Dual PDGF/VEGF antagonists (2017-12-12),

Kodiak Sciences Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing innovative therapies for retinal diseases. The company specializes in advancing novel biologics aimed at improving vision and addressing unmet medical needs in ophthalmology. With a commitment to scientific excellence, Kodiak leverages cutting-edge research and technology to create transformative treatments that enhance patient outcomes and quality of life in the field of eye care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#126 in Palo Alto, CA

#5,317 in California

#22,302 in US

#42,199 in the World

Palo Alto, CA, United States of America

Kodiak Sciences Inc.

Forward Citations = 65

25 inventors:

Daniel Victor Perlroth (10 out of 10 patents)

Wayne To (8 out of 18 patents)

Stephen A Charles (8 out of 22 patents)

4. Didier G Benoit (7 out of 16 patents)

5. Hong Liang (6 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…